Compliance to continuous positive airway pressure therapy in a group of Portuguese patients with obstructive sleep apnea syndrome
Obstructive sleep apnea–hypopnea syndrome (OSAHS) is an emerging public health concern. Although different treatments for OSAHS had been proposed, continuous positive airway pressure (CPAP) is the first-line treatment in moderate to serious OSAHS in which success can be achieved by increasing compliance to CPAP.
Materials and methods
This study analyzes long-term CPAP compliance in patients with OSAHS on CPAP therapy for at least 1 month, who began CPAP therapy between January 2004 and December 2006, followed up at a Portuguese Sleep Outpatient Clinic in Santo António Hospital. Only effective data of CPAP use had been considered. During the first year of CPAP therapy, 96 patients were enrolled and followed up, but 15 patients had discontinued CPAP treatment. CPAP was used on average 5.1 h per day and in 80.1% of the total follow-up days. When compliance is defined as the use of CPAP for a minimum of 4 h per day in at least 70% of the follow-up days, only 54% of patients were classified as compliants during the first year.
Results and conclusion
No statistically significant differences were found throughout the first year (p > 0.05) in terms of the percentage of compliants, controlling for demographic and clinic variables. None of the demographic and clinical baseline variables studied were found to be significant predictor of CPAP compliance (p > 0.05). This study diagnosed a low compliance to CPAP therapy in the studied sample, warning to the need of developing further studies in this area and to the need of implementing strategies to increase CPAP compliance.
KeywordsObstructive sleep apnea–hypopnea syndrome CPAP treatment CPAP compliance
- 3.Giradin JL, Zizi F, Luther C, Brown CD, McFarlane SI (2008) Obstructive sleep apnea and cardiovascular disease: role of metabolic syndrome and its components. J Clin Sleep Med 4(3):261–272Google Scholar
- 12.Veasey SC, Guilleminault C, Strohl KP, Sanders MH, Ballard RD, Magalang UJ (2006) Medical therapy for obstructive sleep apnea: a review by the Medical Therapy for Obstructive Sleep Apnea Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 29(8):1036–1044PubMedGoogle Scholar
- 13.Smith I, Lasserson TJ, Wright JJ (2006) Drug therapy for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2:CD003002. doi:10.1002/14651858.CD003002.pub2
- 15.Sundaram S, Lim J, Lasserson TJ (2005) Surgery for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 4: CD001004. doi:10.1002/14651858.CD001004.pub2
- 16.Giles TL, Lasserson TJ, Smith B, White JJ, Cates CJ (2006) Continuous positive airway pressure for obstructive sleep apnoea in adults (review). Cochrane Database Syst Rev 1: CD001106. doi:10.1002/14651858.CD001106.pub2
- 17.Scottish Intercollegiate Guidelines Network (SIGN) (2003) Management of obstructive sleep apnoea/hypopnoea syndrome in adults (guideline no.73). http://www.sign.ac.uk/pdf/sign73.pdf. Accessed 3 March 2010
- 24.Monasterio C, Vidal S, Duran J, Ferrer M, Carmona C, Barbé F, Mayos M, Gonzalez-Mangado N, Juncadella M, Navarro A, Barreira R, Capote F, Mayoralas LR, Peces-Barba G, Alonso J, Montserrat JM (2001) Effectiveness of continuous positive airway pressure in mild sleep apnea–hypopnea syndrome. Am J Resp Crit Care Med 164:939–943PubMedGoogle Scholar
- 39.Chin K, Shimizu K, Nakamura T, Narai N, Masuzaki H, Ogawa Y, Mishima M, Nakamura T, Nakao K, Ohi M (1999) Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100:706–712PubMedGoogle Scholar
- 50.Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. US Department of Health, Education, and Welfare Public Health Service—NIH/NIND.Google Scholar